Regulatory Guidance on Clonality - Interview with Former FDA CDER Reviewer, Dr Audrey Jia | Advanced instruments

Regulatory Guidance on Clonality – Interview with Former FDA CDER Reviewer, Dr Audrey Jia

Interviews with Former FDA CDER Reviewer, Dr Audrey Jia
For companies involved in cell line development for biotherapeutics